Advanced Search


Study ID Status Title Patient Level Data
201657 Completed Meta-analysis of clinical efficacy studies of licensed Rheumatoid Arthritis (RA) treatments
201659 Terminated An Adaptive Design Open Label Pilot Study in Rheumatoid Arthritis Patients to Assess Inflammation Using Molecular Imaging Techniques
201661 Completed Skin Residency Study of Topically Applied GSK2894512 Cream in Healthy Volunteers
201670 Completed Indirect Comparison of Albiglutide and Exenatide QW using the Bucher method
201674 Completed A Phase I, 2-part relative oral bioavailability study of different fixed dose combinations of dolutegravir and rilpivirine in fasted and fed healthy subjects
201681 Completed An open-label balanced, randomised, single dose, two-way crossover study to determine the bioequivalence of GW483100 10 mg tablets (containing montelukast sodium equivalent to 10 mg of montelukast) relative to reference montelukast sodium 10 mg tablets (containing montelukast sodium equivalent to 10 mg of montelukast) in healthy male and female volunteers under fasting conditions
201682 Completed A randomized, double-blind, placebo controlled study to evaluate the safety, tolerability and clinical effect of oral danirixin (GSK1325756) in the treatment of healthy adults with acute, uncomplicated influenza (201682)
201691 Completed A Phase 1, Open Label, Ascending Cohort, Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Epelsiban and its Metabolite in Healthy Female Volunteers Following Administration of Epelsiban
201703 Completed The Utility of a Clinical Questionnaire to Identify Subjects with Features of Both Asthma and COPD
201713 Completed An Open-label, Randomized, Single Dose, Three-way Crossover, Six Sequence Pilot Study to Determine the Relative Bioavailability of Candesartan Cilexetil 16mg From Two Candidate Tablet Formulations of GW615775 Relative to One 16mg Tablet of Reference Candesartan Cilexetil in Healthy Adult Human Subjects Under Fasting Conditions
201718 Active, Not Recruiting WEUSKOP6069: Exploratory Cluster Analysis: Relovair COPD exacerbation studies - which patients benefit most from ICS?
201722 Completed Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
201724 Active, Not Recruiting HO-14-15325 - Cost of Illness Associated with Early Combination Treatment of BPH in the US
201741 Completed A Phase 1, single-center, randomized, open-label, crossover study to assess the relative bioavailability of Phase III tablet formulation candidates in healthy adult subjects
201752 Completed A Randomized, Placebo-controlled, Double-Blind (Sponsor Unblind), Repeat Dose, Ascending Cohort, Dose Escalation Phase I Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Epelsiban and its Major Metabolite in Healthy Women Volunteers Following Administration of Repeat Dosing of Epelsiban
201761 Completed PGx7610: Genetic Evaluation of Hepatotoxicity in Pazopanib Studies
201769 Completed Exploratory Investigation of Associations between Genome-wide Genetic Variants and Response to Darapladib in the STABILITY (LPL100601) and SOLID-TIMI 52 (SB-480848/033) Trials (PGX7615)
201780 Completed A randomized, open-label, single-period, parallel-group study in healthy subjects to determine the effects of dissolution profile on the pharmacokinetics (via both venous and peripheral micro-samples) of single oral 300 mg doses of Tafenoquine (SB-252263) tablets + 30 mg Tafenoquine stable isotope labelled (SIL) solution
201794 Completed PRJ2363: Quantitative Testing of Prescriber Knowledge about TANZEUMTM (albiglutide) Safety and Use Information
201816 Active, Not Recruiting Patient Experience and Delivery Device Preferences with Belimumab: Follow up Questionnaires and Interviews to the Belimumab Subcutaneous Autoinjector Real Life Use Study in Systemic Lupus Erythematosus (SLE)
201834 Completed A randomized, double-blind, single-dose, placebo controlled, 2-way cross-over study evaluating effect of albiglutide on cholecystokinin-induced gallbladder emptying in fasting healthy subjects
201851 Completed A Pharmacokinetic Study for Systemic Exposure of Twice Daily Topically applied GSK2894512 Cream in Subjects with Atopic Dermatitis
201857 Completed Adjusting for treatment crossover in the METRIC trial comparing trametinib to dacarbazine using the ITT population (based on final data cut off)
201884 Completed Clinical Evaluation of Efficacy at 2 Weeks of Duac® Fixed Dose Combination Gel in Treatment of Facial Acne Vulgaris in Japanese Subjects
201897 Completed An Open-label, Randomized, Single Dose, Two-way Crossover study to Determine the Bioavailability of one Fixed Dose Combination Capsule Formulation of Dutasteride and Tamsulosin Hydrochloride (0.5 mg/0.2 mg) Relative to Coadministration of one Dutasteride 0.5 mg capsule and one Tamsulosin Hydrochloride 0.2 mg tablet in Healthy Male Subjects in the Fed and Fasted States



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.